Lexaria Bioscience Corp. Quarterly Return On Equity in % from Q3 2020 to Q4 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Lexaria Bioscience Corp. quarterly/annual Return On Equity history and growth rate from Q3 2020 to Q4 2024.
  • Lexaria Bioscience Corp. Return On Equity for the quarter ending November 30, 2024 was -88.9 %, a 46.3% increase year-over-year.
  • Lexaria Bioscience Corp. annual Return On Equity for 2024 was -86.1 %, a 44.2% increase from 2023.
  • Lexaria Bioscience Corp. annual Return On Equity for 2023 was -154 %, a 108% decline from 2022.
  • Lexaria Bioscience Corp. annual Return On Equity for 2022 was -74.1 %, a 62.2% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2024 -88.9 +76.5 +46.3% Sep 1, 2024 Nov 30, 2024
Q3 2024 -86.1 +68.1 +44.2% Jun 1, 2024 Aug 31, 2024
Q2 2024 -88.4 +35.6 +28.7% Mar 1, 2024 May 31, 2024
Q1 2024 -134 -32.1 -31.5% Dec 1, 2023 Feb 29, 2024
Q4 2023 -165 -81.9 -98.1% Sep 1, 2023 Nov 30, 2023
Q3 2023 -154 -80.1 -108% Jun 1, 2023 Aug 31, 2023
Q2 2023 -124 -59.2 -91.3% Mar 1, 2023 May 31, 2023
Q1 2023 -102 -37.4 -57.9% Dec 1, 2022 Feb 28, 2023
Q4 2022 -83.5 -35.9 -75.3% Sep 1, 2022 Nov 30, 2022
Q3 2022 -74.1 -28 -60.9% Jun 1, 2022 Aug 31, 2022
Q2 2022 -64.8 -9.17 -16.5% Mar 1, 2022 May 31, 2022
Q1 2022 -64.5 -12.9 -24.9% Dec 1, 2021 Feb 28, 2022
Q4 2021 -47.6 +117 +71% Sep 1, 2021 Nov 30, 2021
Q3 2021 -46.1 +114 +71.2% Jun 1, 2021 Aug 31, 2021
Q2 2021 -55.7 Mar 1, 2021 May 31, 2021
Q1 2021 -51.6 Dec 1, 2020 Feb 28, 2021
Q4 2020 -164 Sep 1, 2020 Nov 30, 2020
Q3 2020 -160 Jun 1, 2020 Aug 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.